American Capital Advisory, LLC Royalty Pharma PLC Transaction History
American Capital Advisory, LLC
- $172 Billion
- Q3 2024
A detailed history of American Capital Advisory, LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, American Capital Advisory, LLC holds 700 shares of RPRX stock, worth $18,564. This represents 0.01% of its overall portfolio holdings.
Number of Shares
700
Previous 900
22.22%
Holding current value
$18,564
Previous $25.3 Million
21.67%
% of portfolio
0.01%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding RPRX
# of Institutions
403Shares Held
292MCall Options Held
305KPut Options Held
138K-
Morgan Stanley New York, NY44.1MShares$1.17 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA38MShares$1.01 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$610 Million0.01% of portfolio
-
Baillie Gifford & CO16.1MShares$428 Million0.35% of portfolio
-
Viking Global Investors LP12MShares$317 Million1.26% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $11.6B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...